XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]        
REVENUES $ 666,521 $ 1,596,129 $ 1,175,790 $ 21,773,829
COST OF REVENUES (180,238) (1,379,123) (293,384) (21,048,586)
GROSS PROFIT 486,283 217,006 882,406 725,243
SELLING (7,965) (292,253) (125,381) (1,564,596)
GENERAL AND ADMINISTRATIVE (516,384) (1,113,805) (2,219,429) (3,137,094)
RESEARCH AND DEVELOPMENT (5,343) (181,502) (85,688) (402,130)
TOTAL OPERATING EXPENSES (529,692) (1,587,560) (2,430,498) (5,103,820)
LOSS FROM OPERATIONS (43,409) (1,370,554) (1,548,092) (4,378,577)
OTHER (EXPENSE) INCOME        
Other income (expense), net 24,079 6,516 36,257 (190,805)
Interest expense (615) (2,572) (2,983) (72,014)
Unrealized holding loss on marketable securities (501,848) (346,705) (169,183) (699,140)
Change in fair value of derivative liabilities 1,781,758 1,781,758
Other income from software developing service, net of cost 675,131
Amortization of debt discount (358,284)
TOTAL OTHER INCOME (EXPENSE), NET 1,303,374 (342,761) 1,645,849 (645,112)
INCOME (LOSS) BEFORE INCOME TAXES 1,259,965 (1,713,315) 97,757 (5,023,689)
PROVISION FOR INCOME TAXES (20,831) (20,852)
NET INCOME (LOSS) 1,259,965 (1,713,315) 76,926 (5,044,541)
OTHER COMPREHENSIVE INCOME (LOSS)        
Foreign currency translation adjustments 2,871 (5,293) (98,093) (5,250)
COMPREHENSIVE INCOME (LOSS) $ 1,262,836 $ (1,718,608) $ (21,167) $ (5,049,791)
INCOME (LOSS) PER SHARE        
Basic (in Dollars per share) [1] $ 1.09 $ (116.03) $ 0.14 $ (732.6)
Diluted (in Dollars per share) [1] $ 1.09 $ (116.03) $ 0.14 $ (732.6)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING        
Basic (in Shares) [1],[2] 1,156,208 14,766 542,963 6,886
Diluted (in Shares) [1],[2] 1,156,208 14,766 542,963 6,886
[1] Giving retroactive effect to the 1-for-50 reverse stock split effected on April 7, 2025
[2] For the three months ended March 31, 2025 and 2024, 23,298 and 28 contingent shares to be issued to the investor, underwriters and convertible note holders are excluded in the diluted EPS calculation due to its anti-diluted effect, respectively. For the nine months ended March 31, 2025 and 2024, 23,298 and 28 contingent shares to be issued to the investor, underwriters and convertible note holders are excluded in the diluted EPS calculation due to its anti-diluted effect, respectively.